The need for continuous renal replacement therapy may be associated with high risk of mortality among adult patients with acetaminophen-induced acute liver failure. Patients with acute liver failure ...
Hosted on MSN
Talphera outlines 2025 timeline for NEPHRO CRRT study completion and FDA approval of Niyad
CEO Vincent Angotti highlighted significant progress in the NEPHRO CRRT study, emphasizing the FDA-approved reduction in study size from 166 to 70 patients while maintaining 90% statistical power for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback